Companies in the Synthetic blood industry

Baxter International is a medical device manufacturing company.

Sanguine is a company that has the mission to accelerate medical research by eliminating the barriers to patient participation.

Resilience Technology Corporation is an Hanover, Maryland-based cybersecurity company developing and manufacturing cyber security tools and founded in 1995.

NuvOx Pharma is an oxygen therapeutics company founded in 2008 by David Wilson.

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

A biotechnology company developing treatments for hematology and oncology diseases

SpheriTech is an independent research, development, and manufacturing company focused on developing novel and innovative polymeric materials which offer wide-ranging application solutions to clients within the life science research, biotechnology, and healthcare industries.

OPK Biotech LLC develops, manufactures and markets oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. Using our patented and proprietary technology, we have developed and manufacture two products: Hemopure® (HBOC-201) [hemoglobin glutamer - 250 (bovine)] for human use, and Oxyglobin® (HBOC-301) [hemoglobin glutamer - 200 (bovine)] for veterinary use. Oxyglobin, for the treatment of all-cause anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration (FDA) and the European Commission. Approximately, 200,000 units have been sold. The Company operates manufacturing facilities in Cambridge, Massachusetts and Souderton Pennsylvania.

Alliance Pharma is a contract Research & Consulting founded in 2008 by Michael Zhang.

The Hemarina technological platform is based on the peculiarities of the purified hemoglobin of lugworms, Arenicola marina . Its structure is comparable to that of human hemoglobin, however it is distinguished by: its extracellular character (it is not contained in a red blood cell), and therefore universal (compatibility with all blood groups) its ability to bind 40 times more oxygen than human hemoglobin its particularly small size: 250 times smaller than the human red blood cell

A biopharmaceutical company developing scientific, clinical and commercial oxygen-therapeutic agents

Hemo Bioscience is a Carolina, Alamance County, North Carolina-based diagnostic tools and medical device company manufacturing transfusion diagnostic devices and related products for blood banks founded in 2003.

Kalocyte, Inc. is an artificial Red Blood Cell founded in 2016 by Allan Doctor, Dipanjan Pan and Philip C. Spinella.

Manufacturer and supplier of approved artificial blood intended to address the worldwide blood shortage. The company's artificial blood is completely synthetic, non-hemoglobin-based and can be used as a blood substitute in trauma, acute blood loss/hemorrhage, severe anemia, treatment of sickle cell disease, recovery from chemotherapy, and other medical situations, eliminating the possibility of viral transmission and can be given to anyone and does not need to be matched to blood type before administration, saving precious time and resources.

Oxyvita Inc. is a polymerized Hemoglobin Oxygen Carrier founded in 2000.

HaemO2 is a biotechnology project based at the University's School of Life Sciences. The beauty of this research at Essex is the scientists have used genetic engineering to decrease the toxicity of haemoglobin in an artificial haemoglobin-based oxygen carrier (HBOC). They have also developed new methods to stabilise the protein outside of the red blood cell.

Developer of an artificial oxygen carrier intended to provide blood substitute and oxygen therapeutic for human use. The company's carrier offers an artificial blood substitute to overcome blood donations and other transfusion-related risks enabling doctors to compensate for blood loss during surgery, save lives of victims or to treat patients with anemia and other illnesses.

Northfield Laboratories Inc. is developing an alternative to transfused blood for use in the treatment of acute blood loss. The Company's PolyHeme blood substitute product is a solution of chemically modified hemoglobin derived from human blood.

Hemoglobin-based oxygen carrier

Green Cross is a Yongin-based company founded in 1967.

Therapure Biopharma Inc. is a contract Biologics founded in 2008.

Competence without borders: The basic competencies of the alliance are manifested in the ability to solve serious multifunctional tasks that require the integration and coordination of efforts of the majority of its members

Pharmaceutical developer creating treatments for various critical health conditions with high unmet medical needs.

Hemobiotech Inc is a Texas-based company.

Hemosol Inc. had trials ongoing in sickle cell disease patients, and in cardiac surgery. They are no longer an active company.